Coloplast Limited is a global healthcare company specializing in the development, manufacture, and marketing of medical products. Established in 1973, the company operates as a limited company with a registered address in Peterborough, England. Coloplast’s core business centers around providing innovative solutions for healthcare professionals and patients. The company’s primary focus is on intermittent catheters, a critical component of its portfolio. These catheters are designed for a range of applications, including urinary incontinence, pelvic floor dysfunction, and other related conditions. Coloplast’s expertise extends to the entire lifecycle of these products, from research and development to manufacturing and distribution. Coloplast’s international presence is significant, with operations spanning numerous countries worldwide. The company employs a diverse workforce, emphasizing skilled professionals and technicians. Coloplast’s business model is characterized by a commitment to continuous innovation, driven by a dedicated research and development team. The company’s strategic focus is on expanding its product offerings and strengthening its position within the global healthcare market. The company’s SIC codes encompass a broad range of industries including medical devices, pharmaceuticals, and healthcare products, reflecting its multifaceted business operations.

Coloplast Limited is a global healthcare company specializing in the development, manufacture, and marketing of medical products. Established in 1973, the company operates as a limited company with a registered address in Peterborough, England. Coloplast’s core business centers around providing innovative solutions for healthcare professionals and patients. The company’s primary focus is on intermittent catheters, a critical component of its portfolio. These catheters are designed for a range of applications, including urinary incontinence, pelvic floor dysfunction, and other related conditions. Coloplast’s expertise extends to the entire lifecycle of these products, from research and development to manufacturing and distribution. Coloplast’s international presence is significant, with operations spanning numerous countries worldwide. The company employs a diverse workforce, emphasizing skilled professionals and technicians. Coloplast’s business model is characterized by a commitment to continuous innovation, driven by a dedicated research and development team. The company’s strategic focus is on expanding its product offerings and strengthening its position within the global healthcare market. The company’s SIC codes encompass a broad range of industries including medical devices, pharmaceuticals, and healthcare products, reflecting its multifaceted business operations.